SEARCH

SEARCH BY CITATION

References

  • 1
    Rapaport SI, Aas K, Owren PA. The effect of glass upon the activity of the various plasma clotting factors. J Clin Invest 1955; 34: 919.
  • 2
    Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961; 36: 2129.
  • 3
    Schiffman S, Rapaport SI, Patch MJ. The identification and synthesis of activated plasma thromboplastin component (PTC). Blood 1963; 22: 73349.
  • 4
    Rimon A, Schiffman S, Feinstein DI, Rapaport SI. Factor XI activity and factor XI antigen in homozygous and heterozygous factor XI deficiency. Blood 1976; 48: 16574.
  • 5
    Rapaport SI, Schiffman S, Patch MJ, Ames SB. The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. Blood 1963; 21: 22136.
  • 6
    Schiffman S, Rapaport SI, Chong MM. The mandatory role of lipid in the interaction of factors 8 and 9. Proc Soc Exp Biol Med 1966; 123: 73640.
  • 7
    Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A 1977; 74: 52604.
  • 8
    Seligsohn U, Kasper CK, Østerud B, Rapaport SI. Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood 1979; 53: 82837.
  • 9
    Sanders NL, Bajaj SP, Zivelin A, Rapaport SI. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood 1985; 66: 20412.
  • 10
    Rao LVM, Rapaport SI. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood 1987; 69: 64551.
  • 11
    Sandset PM, Warn-Cramer BJ, Rao LVM, Maki SL, Rapaport SI. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci U S A 1991; 88: 70812.
  • 12
    Sandset PM, Warn-Cramer BJ, Maki SL, Rapaport SI. Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized schwartzman reaction. Blood 1991; 78: 1496502.
  • 13
    Feinstein D, Chong MN, Kasper CK, Rapaport SI. Hemophilia A: polymorphism detectable by a factor 8 antibody. Science 1969; 163: 10712.
  • 14
    Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972; 1: 7595.
  • 15
    Rapaport SI, Ames SB, Mikkelsen S, Goodman JR. Plasma clotting factors in chronic hepatocellular disease. N Engl J Med 1960; 263: 27882.
  • 16
    Henderson ES, Rapaport SI. The thrombotic activity of activation product. J Clin Invest 1962; 41: 23544.
  • 17
    Østerud B, Rapaport SI. Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IX. Biochemistry 1970; 9: 185461.
  • 18
    Feinstein DI, Rapaport SI, McGehee WG, Patch MJ. Factor V anticoagulants: clinical, biochemical, and immunological observations. J Clin Invest 1970; 49: 157888.
  • 19
    Østerud B, Rapaport SI, Lavine KK. Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood 1977; 49: 81934.
  • 20
    Seligsohn U, Østerud B, Brown SF, Griffin JH, Rapaport SI. Activation of Human Factor VII in Plasma and in Purified Systems. J Clin Invest 1979; 64: 105665.
  • 21
    Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983; 61: 68492.
  • 22
    Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zielin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 55962.
  • 23
    Rao LVM, Rapaport SI. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci U S A 1988; 85: 668791.
  • 24
    Rao LVM, Rapaport SI. Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa. Blood 1990; 75: 106973.
  • 25
    Rapaport SI. Introduction to Hematology. Philadelphia: J.B. Lippincott Company, 1971.